Journal article
Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy
PloS one, Vol.11(10), pp.e0164135-e0164135
2016
DOI: 10.1371/journal.pone.0164135
PMCID: PMC5051905
PMID: 27706238
Abstract
Diabetic nephropathy (DN) is the leading cause of end-stage kidney disease worldwide but current treatments remain suboptimal. The role of inflammation in DN has only recently been recognized. It has been shown that the NLRP3-inflammasome contributes to DN development by inducing interleukin (IL)-1β processing and secretion. In an effort to understand other IL-1β activating mechanism during DN development, we examined the role of the NLRC4-inflammasome in DN and found that NLRC4 is a parallel mechanism, in addition to the NLRP3-inflammasome, to induce pro-IL-1β processing and activation. We found that the expression of NLRC4 is elevated in DN kidneys. NLRC4-deficiency results in diminished DN disease progression, as manifested by a decrease in blood glucose and albumin excretion, as well as preserved renal histology. We further found that DN kidneys have increased F4/80+ macrophages, increased IL-1β production, and other signaling pathways related to kidney pathology such as activation of NF-κB and MAP kinase pathways, all of which were rescued by NLRC4-deficiency. This study demonstrates NLRC4-driven IL-1β production as critical for the progression of DN, which underscores the importance to target this pathway to alleviate this devastating disease.
Details
- Title: Subtitle
- Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy
- Creators
- Fang Yuan - Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA, United States of AmericaRyan Kolb - Interdisciplinary Graduate Program in Immunology, University of Iowa Carver College of Medicine, Iowa City, IA, United States of AmericaGaurav Pandey - Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA, United States of AmericaWei Li - Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA, United States of AmericaLin Sun - Department of Nephrology, the Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, Hunan ChinaFuyou Liu - Department of Nephrology, the Second Xiangya Hospital, Research Institute of Nephrology, Central South University, Changsha, Hunan ChinaFayyaz S Sutterwala - Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States of AmericaYinghong Liu - Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA, United States of AmericaWeizhou Zhang - Cancer Genes and Pathway Holden Comprehensive Cancer Center, University of Iowa Carver College of Medicine, Iowa City, IA, United States of America
- Resource Type
- Journal article
- Publication Details
- PloS one, Vol.11(10), pp.e0164135-e0164135
- DOI
- 10.1371/journal.pone.0164135
- PMID
- 27706238
- PMCID
- PMC5051905
- NLM abbreviation
- PLoS One
- ISSN
- 1932-6203
- eISSN
- 1932-6203
- Publisher
- Public Library of Science
- Grant note
- R00 CA158055 / NCI NIH HHS R01 CA203834 / NCI NIH HHS K99 CA158055 / NCI NIH HHS R01 CA200673 / NCI NIH HHS T32 AI007260 / NIAID NIH HHS
- Language
- English
- Date published
- 2016
- Academic Unit
- Radiation Oncology
- Record Identifier
- 9984083877602771
Metrics
16 Record Views